Research progress of atorvastatin gene polymorphism
10.12206/j.issn.2097-2024.202110042
- VernacularTitle:阿托伐他汀的基因多态性研究进展
- Author:
Qin HUANG
1
,
2
;
Gele SUONAN
3
;
Wenbin LI
4
;
Yuemei SUN
4
;
Rong WANG
1
,
2
Author Information
1. The Altitude Medicine Laboratory of the People’s Liberation Army, No. 940 Hospital of Joint Logistics Support Force, Lanzhou 730050, China
2. School of Pharmacy, Lanzhou University, Lanzhou 730050, China.
3. Department of Internal Medicine, Yushu Prefecture People's Hospital, Yushu 815000, China.
4. The Altitude Medicine Laboratory of the People’s Liberation Army, No. 940 Hospital of Joint Logistics Support Force, Lanzhou 730050, China.
- Keywords:
atorvastatin;
blood lipids;
drug metabolizing enzymes;
drug transporters;
gene polymorphisms
- From:
Journal of Pharmaceutical Practice and Service
2022;40(5):416-421
- CountryChina
- Language:Chinese
-
Abstract:
Atorvastatin is a blood lipid-lowering drug widely used clinically. Long-term use can prevent and reduce the occurrence of atherosclerotic cardiovascular disease (ASCVD). However, the efficacy of atorvastatin has significant inter-individual differences. Some individuals failed to achieve the expected lipid-lowering target value or had serious adverse reactions, which were related to the genetic diversity between individuals. Genetic variation can lead to differences in drug configuration, clinical efficacy and adverse reactions. The drug metabolism enzymes, drug transporters, drug targets and genetic polymorphisms related to lipid metabolism were reviewed in this paper that affect the drug response of atorvastatin, and from the gene level to explore the reasons for the differences in the pharmacokinetics, pharmacodynamics and susceptibility to adverse reactions of different individuals using atorvastatin.
